These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 10320519

  • 1. Growth hormone increases cortical and cancellous bone mass in young growing rats with glucocorticoid-induced osteopenia.
    Ortoft G, Andreassen TT, Oxlund H.
    J Bone Miner Res; 1999 May; 14(5):710-21. PubMed ID: 10320519
    [Abstract] [Full Text] [Related]

  • 2. Growth hormone can reverse glucocorticoid-induced low bone turnover on cortical but not on cancellous bone surfaces in adult Wistar rats.
    Ortoft G, Andreassen TT, Oxlund H.
    Bone; 2005 Jan; 36(1):123-33. PubMed ID: 15664010
    [Abstract] [Full Text] [Related]

  • 3. The anabolic effect of PTH on bone is attenuated by simultaneous glucocorticoid treatment.
    Oxlund H, Ortoft G, Thomsen JS, Danielsen CC, Ejersted C, Andreassen TT.
    Bone; 2006 Aug; 39(2):244-52. PubMed ID: 16503210
    [Abstract] [Full Text] [Related]

  • 4. The influence of growth hormone on cancellous and cortical bone of the vertebral body in aged rats.
    Andreassen TT, Melsen F, Oxlund H.
    J Bone Miner Res; 1996 Aug; 11(8):1094-102. PubMed ID: 8854245
    [Abstract] [Full Text] [Related]

  • 5. How cancellous and cortical bones adapt to loading and growth hormone.
    Kalu DN, Banu J, Wang L.
    J Musculoskelet Neuronal Interact; 2000 Sep; 1(1):19-23. PubMed ID: 15758520
    [Abstract] [Full Text] [Related]

  • 6. Effects of alendronate and strontium ranelate on cancellous and cortical bone mass in glucocorticoid-treated adult rats.
    Sun P, Cai DH, Li QN, Chen H, Deng WM, He L, Yang L.
    Calcif Tissue Int; 2010 Jun; 86(6):495-501. PubMed ID: 20390406
    [Abstract] [Full Text] [Related]

  • 7. Administration of a glucocorticoid with depot effect counteracts the stimulating effect of growth hormone on cancellous and cortical bone of the vertebral body in rats.
    Ortoft G, Oxlund H, Andreassen TT.
    Calcif Tissue Int; 1998 Jul; 63(1):14-21. PubMed ID: 9632841
    [Abstract] [Full Text] [Related]

  • 8. Continuous parathyroid hormone and estrogen administration increases vertebral cancellous bone volume and cortical width in the estrogen-deficient rat.
    Zhou H, Shen V, Dempster DW, Lindsay R.
    J Bone Miner Res; 2001 Jul; 16(7):1300-7. PubMed ID: 11450706
    [Abstract] [Full Text] [Related]

  • 9. Early induction of alterations in cancellous and cortical bone histology after orchiectomy in mature rats.
    Gunness M, Orwoll E.
    J Bone Miner Res; 1995 Nov; 10(11):1735-44. PubMed ID: 8592951
    [Abstract] [Full Text] [Related]

  • 10. Lack of an effect of sodium zeolite A on rat tibia histomorphometry.
    Firling CE, Evans GL, Wakley GK, Sibonga J, Turner RT.
    J Bone Miner Res; 1996 Feb; 11(2):254-63. PubMed ID: 8822350
    [Abstract] [Full Text] [Related]

  • 11. The thyroid hormone receptor beta-specific agonist GC-1 selectively affects the bone development of hypothyroid rats.
    Freitas FR, Capelo LP, O'Shea PJ, Jorgetti V, Moriscot AS, Scanlan TS, Williams GR, Zorn TM, Gouveia CH.
    J Bone Miner Res; 2005 Feb; 20(2):294-304. PubMed ID: 15647824
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Simvastatin treatment partially prevents ovariectomy-induced bone loss while increasing cortical bone formation.
    Oxlund H, Andreassen TT.
    Bone; 2004 Apr; 34(4):609-18. PubMed ID: 15050891
    [Abstract] [Full Text] [Related]

  • 14. A nonprostanoid EP4 receptor selective prostaglandin E2 agonist restores bone mass and strength in aged, ovariectomized rats.
    Ke HZ, Crawford DT, Qi H, Simmons HA, Owen TA, Paralkar VM, Li M, Lu B, Grasser WA, Cameron KO, Lefker BA, DaSilva-Jardine P, Scott DO, Zhang Q, Tian XY, Jee WS, Brown TA, Thompson DD.
    J Bone Miner Res; 2006 Apr; 21(4):565-75. PubMed ID: 16598377
    [Abstract] [Full Text] [Related]

  • 15. The complex of recombinant human insulin-like growth factor-I (rhIGF-I) and its binding protein-5 (IGFBP-5) induces local bone formation in murine calvariae and in rat cortical bone after local or systemic administration.
    Bauss F, Lang K, Dony C, Kling L.
    Growth Horm IGF Res; 2001 Feb; 11(1):1-9. PubMed ID: 11437468
    [Abstract] [Full Text] [Related]

  • 16. The effects of growth hormone on cortical and cancellous bone.
    Andreassen TT, Oxlund H.
    J Musculoskelet Neuronal Interact; 2001 Sep; 2(1):49-58. PubMed ID: 15758476
    [Abstract] [Full Text] [Related]

  • 17. Effect of vitamin K2 on cortical and cancellous bones in orchidectomized and/or sciatic neurectomized rats.
    Iwamoto J, Yeh JK, Takeda T.
    J Bone Miner Res; 2003 Apr; 18(4):776-83. PubMed ID: 12674339
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Qualitative alterations of cortical bone in female rats after long-term administration of growth hormone and glucocorticoid.
    Ortoft G, Oxlund H.
    Bone; 1996 Jun; 18(6):581-90. PubMed ID: 8806000
    [Abstract] [Full Text] [Related]

  • 20. A new vitamin D analog, 2MD, restores trabecular and cortical bone mass and strength in ovariectomized rats with established osteopenia.
    Ke HZ, Qi H, Crawford DT, Simmons HA, Xu G, Li M, Plum L, Clagett-Dame M, DeLuca HF, Thompson DD, Brown TA.
    J Bone Miner Res; 2005 Oct; 20(10):1742-55. PubMed ID: 16160732
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.